One of the world's 20 largest pharmaceutical companies, Boehringer Ingelheim Pharmaceuticals, Inc., has entered into a partnership with Solve.Care, to launch a patient-centric care network on the Solve.Care blockchain platform, states the official press release.
Solve.Care is a global healthcare platform which uses blockchain technology for the administration, coordination and payments of healthcare benefits.
According to the announcement, the partnership aims to improve the well-being of patients with diabetes, and "who may also be at an increased risk for cardiovascular disease."
Graham Goodrich, Vice President & Cardiometabolic Marketing at Boehringer Ingelheim claims recent changes to diabetes treatment recommendations "have prioritized managing cardiovascular risk, and this program will help ensure both patients and providers are proactively addressing life-threatening cardiovascular complications associated with this chronic condition."
"We are proud to join Solve.Care and the Arizona Care Network to provide patients and providers with additional solutions to help address diabetes and cardiovascular disease," he added.
Last year, BlackBerry entered into several new partnerships in healthcare and blockchain aimed at improving patient outcomes through the use of the BlackBerry Spark platform and the Enterprise of Things.
Subscribe to our Telegram channel to stay up to date on the latest crypto and blockchain news.